SCHEMBL10714240

SCHEMBL10714240

O=C1Cc2cc(Br)cc(-c3ccccc3)c2N1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP2 O95551 11/20 0.49
▸ CYP19A1 P11511 2/20 0.45
▸ CYP11B1 P15538 2/20 0.45
▸ CYP11B2 P19099 2/20 0.45
▸ CHEK1 O14757 1/20 0.44
▸ AURKA O14965 1/20 0.44
▸ DAPK3 O43293 1/20 0.44
▸ PRKD3 O94806 1/20 0.44
▸ MAP4K4 O95819 1/20 0.44
▸ ABL1 P00519 1/20 0.44
▸ NTRK1 P04629 1/20 0.44
▸ CSF1R P07333 1/20 0.44
▸ RET P07949 1/20 0.44
▸ MET P08581 1/20 0.44
▸ PDGFRB P09619 1/20 0.44
▸ PIM1 P11309 1/20 0.44
▸ FGFR1 P11362 1/20 0.44
▸ PDGFRA P16234 1/20 0.44
▸ FLT1 P17948 1/20 0.44
▸ LTK P29376 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10714905 0.85 TDP2 (0.52) TDP2AHRCMA1GRIA1CACNG8
SCHEMBL31117027 0.85 TDP2 (0.52) TDP2NTRK1METFGFR1KDR
SCHEMBL10714430 0.81 TDP2 (0.49) TDP2CYP19A1CYP11B1CYP11B2CHEK1
SCHEMBL10713979 0.81 TDP2 (0.49) TDP2CYP19A1CYP11B1CYP11B2CHEK1
SCHEMBL10712665 0.77 AHR (0.56) TDP2CYP19A1CYP11B1CYP11B2CHEK1
SCHEMBL5373768 0.74 TDP2 (0.49) TDP2CYP19A1CYP11B1CYP11B2AHR
SCHEMBL4297627 0.71 TDP2 (0.46) TDP2AHRCMA1PDK2GRIA1
SCHEMBL18189576 0.71 AHR (0.53) TDP2CYP11B1CYP11B2AHRCMA1
SCHEMBL5363780 0.71 TDP2 (0.46) TDP2AHRCMA1PDK2GRIA1
SCHEMBL10712589 0.71 GRIA1 (0.52) TDP2CYP19A1CYP11B1CYP11B2CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4670566-A ANTIIFLAMMATORY AGENTS, ANTICOAGULANTS A. H. ROBINS COMPANY, INCORPORATED (US) 1987-06-02 — — US disclosed
US-4440785-A Methods of using 2-aminobiphenylacetic acids, esters, and metal salts thereof to treat inflammation A. H. ROBINS COMPANY, INC. (US) 1984-04-03 — — US disclosed
Send feedback